Charles River Labs stock holds support as investors wait for fresh numbers.

Charles River Labs (US1591881009) is being read through its latest reported numbers rather than a single headline catalyst, with the stock framed by a 52-week range of $? and a market value of $? as of 16 July 2026.

Revenue and margin base

The companys most recent quarterly figures show revenue of $?, adjusted EPS of $?, and an operating margin of $? for the period ended ?.

That comparison matters because the same report also showed revenue changing by $? year over year, giving investors a concrete reference point for the current valuation discussion.

What the latest quarter says

On the operating side, Charles River Labs reported $? in free cash flow, $? in debt, and $? in segment or service revenue, which together define the balance between growth and capital discipline.

Those figures are most useful when read against the prior period, because the companys quarterly update also established whether the business was expanding, stabilizing, or losing pace on a reported basis.

Discovery and development services

The product and service mix is still led by laboratory and discovery support work, which remains the companys core commercial engine and the area that will most directly shape reported revenue in future quarters.

Stock level and context

Charles River Labs stock is best read against the latest trading band and the last reported operating numbers, with the market still weighing revenue, EPS, and cash generation together.